Publications

1. Advice - do not reimburse 9vHPV vaccine (Gardasil 9®) against cancer due to HPV virus for certain women

   The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) not to reimburse 9vHPV vaccine ...

   Report | 08-10-2024

2. Taking care of good healthcare

   The National Health Care Institute works to ensure adequate insured healthcare services for everyone in the Netherlands, now and ...

   Video | 03-10-2024

3. Advice - reimburse fluorouracil cream (Tolak®) for the treatment of the skin condition actinic keratosis

   The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse 5-fluorouracil 4% ...

   Report | 02-10-2024

4. Advice - reimburse mometasone/olopatadine nasal spray (Ryaltris®) for the treatment of allergic rhinitis

   The National Health Care Institute has advised the minister of Health, Welfare and Sport to reimburse mometasone/olopatadine ...

   Report | 24-09-2024

5. Advice - continue reimbursing nirmatrelvir/ritonavir (Paxlovid®) for the treatment of COVID-19

   Paxlovid® can be used for treating adults with a coronavirus infection (COVID-19) and a very high risk of severe progression of ...

   Report | 18-09-2024

6. Advice - reimburse lebrikizumab (Ebglyss®) for the treatment of moderate to severe eczema

   The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse lebrikizumab ...

   Report | 12-09-2024

7. Advice - reimburse ipilimumab (Yervoy®) for the treatment of one particular form of skin cancer

   The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse ipilimumab (Yervoy®) ...

   Report | 30-08-2024

8. Advice - reimburse zilucoplan (Zilbrysq®) for the treatment of myasthenia gravis

   The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse zilucoplan ...

   Report | 29-08-2024

9. Advice - reimburse tebentafusp (Kimmtrak®) for the treatment of eye cancer

   The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to reimburse tebentafusp ...

   Report | 29-08-2024

10. Advice - expansion of the reimbursement conditions for inclisiran (Leqvio®) and bempedoic acid (Nilemdo®)

    The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to amend the List 2 conditions for ...

    Report | 29-08-2024